|
|
After the success of last year's conference, SMi is proud to present their 4th Annual Adaptive Designs in Clinical Drug Development.
This conference is aimed at exploring the potential of adaptive trials now and in the future through looking at the process, from design through to implementation. The process will be emphasised and explained at all times by reference to real case studies.
You will hear presentations from the key players in the adaptive arena on the big questions adaptive design. Is an adaptive design suitable for my needs? What is the regulatory position on adaptive design? How do I build in adaption to my design? Will a seamless design prove any benefit? How do you manage the additional challenges of data collection, storage and manipulation? Where is the future for adaptive designs?
Attend this event to learn what adaptive designs can add to your clinical drug development experience.
|
|
Fancy speaking at the conference? Do you know of anyone who may be interested in speaking? We are always on the look-out for new speakers for our upcoming conferences. Let us know: smiproduction@smi-online.co.uk.
For sponsorship and exhibitioning opportunities, contact sponsorshipdept@smi-online.co.uk
|
 |
Why should you attend this event?
|
Attend and be updated on:
Regulation - how the new FDA guidelines are shaping the adaptive market and how they fit in with EMEA and Japanese regulations
Trial Design - designing a successful adaptive trial
Implementing Adaptive Designs - through case studies you will get practical advice on how to overcome the challenges presented by adaptive trials
Maintaining Data Integrity - how to keep control of your data
The Future - where the industry goes from here
|
 |
 |
Key benefits of attending:
Listen to some of the most important and influential experts currently working in adaptive designs
Study the current issues surrounding designing and carrying out adaptive trials
Learn about the future potential for the pharmaceutical industry
Network with people you want to meet from the adaptive design arena
|
Feedback from SMi's Adaptive Designs 2009:
"Very good speakers; intelligent, timely topics - it gave me a lot to think about" - Senior Representative, Eli Lilly
""Better than other conferences, more focused" - Senior Representative, Genentech
"Compared to other conferences, SMi was great. The organisation, conference matierials, quality of presentations and venue were all excellent" - Senior Representative, Biogen Idec
Hear keynote addresses from:
|
Alun Bedding
Director, Biostatistics and Programming Development Partners, Drug Development Sciences
GlaxoSmithKline
Carl-Fredrik Burman
Senior Principal Scientist
AstraZeneca
Graeme Archer
Director, Neurosciences Discovery Biometrics
GlaxoSmithKline
|
Robert Clay
Vice President Regulatory Affairs, Oncology and Infection
AstraZeneca
Edwin Wagena
Vice President Clinical Development
Kiadis Pharma
Junfang Li
Director, Biostatistics & Programming Department
Sanofi-Aventis
|
Our expert speaker line-up also includes:
Yili Pritchett, Research Fellow, Director Clinical Statistics, Abbott Laboratories
David Lawrence, Senior Statistician, Novartis
Vera Lisovskaja, Researcher, Biostatistics, AstraZeneca
Stephane Deleger, Manager, Business Development, United BioSource
Christopher Jennison, Professor of Statistics, University of Bath
Barbara Bogacka, Reader in Probability and Statistics, Queen Mary, University of London
Sue Todd, Reader in Medical Statistics, University of Reading
Yu Shyr, Professor and Chief, Division of Cancer Biostatistics, Vanderbilt University
Pantelis Vlachos, Principal Biostatistician, Merck Serono
Caroline Morgan, Clinical Operations Director, Cardinal Systems
Yannis Jemiai, Associate Director of Biostatistics, Cytel
Who should attend?
Chief Executives, Vice Presidents, Heads, Directors, Scientists and Project Leaders of:
- Clinical Drug Development
- Trial Design
- Biostatistics
- Regulatory Affairs
- Contract Research Organisations
- Clinical Operations
- Pharmacokinetics
- Pharmacodynamics
- Research and Development
- Intellectual Property
- Legislation & Policy Advice
- Drug and Safety Assessment
- Clinical Pharmacology
- Experimental Medicine
|
Our 2008 and 2009 attendees came from:
|
Who is attending this year?
Our speakers come from a wide range of international companies and organisations across the pharmaceutical sector - in addition, we already have senior representatives from the following organisations registered to attend:
- Schering-Plough
- MedImmune
- Sanofi-Aventis
- Cephalon
- University of Florida
- Université Paris-Sud 11
- FOCUS Clinical Drug Development
- Simulations Plus Inc
- B&C Group
2009 Delegates worked for:
Johnson & Johnson GlaxoSmithkline Sanofi-Aventis AstraZeneca Merck Serono Eli Lilly Biogen Idec Biovitrium AB Shire PLC BTG Thomson Reuters University of Cologne Syntaxin Hum-Molgen Genentech
Venue details
|
Crowne Plaza St James Hotel
45-51 Buckingham Gate
London
SW1E 6AF
Tel: +44 (0) 207 834 6655
Fax: +44 (0) 207 6307
www.london.crowneplaza.com
|
 |
Crowne Plaza St James London is a traditional deluxe hotel right in the heart of the city, perfectly situated for all your business and leisure needs. In the heart of Westminster, it is just a stone's throw away from Buckingham Palace, The Houses of Parliament, the London Eye and Victoria Station.
The hotel boasts three excellent restaurants. Bistro 51 with British and European cuisine, the Michelin Starred Indian restaurant Quilon serving south coastal Indian food and Bank Westminster with a modern British menu.
A beautiful, award-winning, courtyard garden surrounds the Victorian buildings of the Crowne Plaza London St James - a peaceful oasis in the centre of London.
 |
Booking:
Book your accommodation at SMi discounted rates by:
SMi discounted rates include Continental Breakfast & VAT
- £ 205.63 / Standard room / night for single occupancy
- £ 229.13 Executive room / night for single occupancy
|
|
Events Home Page
